EIMEAR P. BONNER - 28 Jan 2026 Form 4 Insider Report for CHEVRON CORP (CVX)

Role
Chief Financial Officer
Signature
/s/ Rose Z. Pierson, Attorney-in-Fact for Eimear P. Bonner
Issuer symbol
CVX
Transactions as of
28 Jan 2026
Net transactions value
-$449,252
Form type
4
Filing time
30 Jan 2026, 16:38:37 UTC
Previous filing
07 Jan 2026
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BONNER EIMEAR P Chief Financial Officer 1400 SMITH STREET, HOUSTON /s/ Rose Z. Pierson, Attorney-in-Fact for Eimear P. Bonner 30 Jan 2026 0001880440

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVX Common Stock Options Exercise $831,528 +7,534 +173% $110.37 11,900 28 Jan 2026 Direct F1
transaction CVX Common Stock Sale $1,280,780 -7,534 -63% $170.00 4,366 28 Jan 2026 Direct F1
holding CVX Common Stock 408 28 Jan 2026 Share Incentive Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -7,534 -100% $0.000000 0 28 Jan 2026 Common Stock 7,534 $110.37 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2025.
F2 Option granted 1/29/2020. One-third of the shares subject to the option vested on January 31, 2021, January 31, 2022 and January 31, 2023, respectively.